Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Waiting patiently for EU Approval on Dacogen AML.
http://www.businessweek.com/news/2012-08-21/astex-climbs-on-expected-european-approval-san-francisco-mover
SA article: Strong Buy ASTX and ACAD
http://seekingalpha.com/article/878221-under-construction-rehash-buy-acadia-and-astex?source=yahoo
I am holding ASTX for the EU Approval, should be a nice ride.
ASTX - major catalyst by end of September(3rd Quarter), expecting EU Approval for marketing on AML Dacogen. On July 20, 2012, announcement of EU Panel giving approving for AML Dacogen. Company has plenty of cash, turning profitable last 2 quarters. Pipelines are advancing.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/07/astex-dacogen-aml-leukemia.html
http://astx.com/pipeline/products/
ASTX - major catalyst by end of September(3rd Quarter), expecting EU Approval for marketing on AML Dacogen. On July 20, 2012, announcement of EU Panel giving approving for AML Dacogen. Company has plenty of cash, turning profitable last 2 quarters. Pipelines are advancing.
http://www.bizjournals.com/sanfrancisco/blog/biotech/2012/07/astex-dacogen-aml-leukemia.html
http://astx.com/pipeline/products/
Prediction on votes. 9-4. good luck all
Dav, I'm in CRTX. Will hold for tomorrow's Ad comm meeting.
Should be positive votes. Thoughts?
NAVB, disappointed this one did not get approval. However, manufacturing is easy fix. Hopefully it will be class 2 and get a FDA date early next year. I did not want to get paper cut for a few months, decided to get out yesterday near high. I am looking to re-enter around re-submit/FDA acceptance which will be next catalyst.
Meanwhile, I added CRTX. This one can have a big surge if strong positive panel votes. Good luck to all holding.
trade2much, i agree that oncology drugs have been in high demand from the public and government has pushed for expedited usage quicker the last few years. I can't wait till decision. Good luck to us and all that are holding NAVB.
Do you have lots of CRTX? I will add most likely add after NAVB decision.
Thanks trade2much. NAVB does have high chances for FDA approval. That would be nice if Cardinal does buyout NAVB soon.
CRTX may go down a bit further after they release the abstract pages 2 days before FDA panel vote, usually negative stuff to spook investors. I do like this one, will watch closely for my nibble/add.
I added today despite all the talk of shorts on NAVB. I'm expecting FDA approval, FDA delayed decision for 3 months and NAVB provided CMC data(manufacturing).
Trade2much, added significant shares of NAVB today. I'm expecting FDA approval on Monday. Keeping close watch on CRTX.
Thoughts on these two?
whether you like the stock or not, its cheap at these levels for a 100 million cap company with advanced pipelines. I thought it was fishy when someone shorts a company, says AMPE is going to $2.80 on seekingalpha then publishes a short article following day to get his biased agenda done. i see a rally at these prices to above $3.00 again in near term
AMPE has had a run recently with bullish news article then followed by bear/short article back to $2.75 which I feel is a bottom.
Watch for Friday's action, could be a rally at these prices.
August 2012 Presentation, great read
http://ampiopharma.com/wp-content/uploads/2011/06/Ampio-Corporate-Presentation-August-20121.pdf
another great day for AMPE. this thing is only getting warmed up.
few pipelines that are very advanced stages.
http://ampiopharma.com/wp-content/uploads/2011/06/Ampio-Corporate-Presentation-August-20121.pdf
Another up day for AMPE. This thing is getting warmed up.
I missed PPHM to enter at $0.60, its multiplied many times since early July. Roth Capital has $5.00 price target. It may have a slightly more room to run before sell off again.
AMPE with nice surge today. Has potential to run by looking at technical chart. Several pipelines with advanced stages in phase trials. FDA trial design and consult. Positive PR news could ignite this stock.
I'm watching NAVB, could be great biotech to enter before FDA decision in September.
AMPE with nice surge today. More uptrend to come and positive PR from company soon. Several pipelines with advanced stages in phase trials. FDA trial design and consult.
I'm watching NAVB, could be great biotech to enter before FDA decision in September.
I've been adding to AMPE. Some big buys towards market close.
August presentation looks good.
http://ampiopharma.com/wp-content/uploads/2011/06/Ampio-Corporate-Presentation-August-20121.pdf
AMPE looks bottomed out. some big buys at the close of the market, due to release of presentation. lets see if the company announces positive news soon.
http://ampiopharma.com/wp-content/uploads/2011/06/Ampio-Corporate-Presentation-August-20121.pdf
AMPE looks bottomed out. some big buys at the close of the market, due to release of presentation. lets see if the company announces positive news soon.
http://ampiopharma.com/wp-content/uploads/2011/06/Ampio-Corporate-Presentation-August-20121.pdf
AMPE, getting ready for a run. Chart is attractive under $3 to $6.
Surf,
I added AMPE this week. Looks very discounted for biotech company with drug pipelines in advanced stages that can possibly get drugs FDA approved in 1-2 years. Still like it?
AMPE positive meeting with FDA regarding Optina. Promising biotech, bottomed at $3. The long term chart shows a run to $5-$6 can be the uptrend.
http://finance.yahoo.com/news/ampio-announces-successful-pre-ind-080000205.html
http://beta.fool.com/richardcavalli/2012/07/20/ampio-pharmaceuticals-expands-pipeline-new-cancer-/7452/?ticker=ARNA&source=eogyholnk0000001
AMPE positive meeting with FDA regarding Optina.
http://finance.yahoo.com/news/ampio-announces-successful-pre-ind-080000205.html
AMPE seems interesting. Here's what I have thus far:
http://beta.fool.com/richardcavalli/2012/07/20/ampio-pharmaceuticals-expands-pipeline-new-cancer-/7452/?ticker=AMPE&source=eogyholnk0000001
http://www.biopharmcatalyst.com/fda-calendar/
Volume seems somewhat light. There are some shorts in this stock. If positive news soon, this can take off in a hurry. Seems bottomed at $3.
Its good to hear from you trad2much. PGNX got slaughtered, my worst pick yet. I know for PDUFA hold thru, there should be at least a CRL for the company to understand what to improve upon before I should hold thru approval on 1st time FDA decision - better chances.
I added AMPE today and watching TLON for entry point on sell off day(if given before FDA decision).
Anyone in holding PGNX for tomorrow's decision?
no matter what your perspective may be, JAG is bouncing up above $1.00 soon. I originally had 2 assessments after the board & execs being booted/resigned would lead to: strong turnaround of the company or sale of company. Investors could be thinking JAG may be strapped for cash and need to find a solution to it quickly for the cause of the drop in price since beginning July. As bearish as anyone could view this stock, its due for a dead cat bounce for a few days.
Apparently, Deutsche Bank is stating Jaguar Mining will be a takeover target from June 18. I read this from the yahoo board. Anyone can confirm the news is accurate? Regardless, JAG has bled so much and way too much versus book value. I expect it to bounce before end of the week(gold rally as well).
Trade2much! I'm waiting to see if ARNA dips below $8 to add position for Wednesday's FDA Decision. Any thoughts?
I continued to add as prices dropped below $1.40 We are just warming up for the gold rally! Lets make some $$$ folks.
trade2much, thanks for the reply. I do like NAVB, traded this multiple times and profited nicely. I also like AMRN, will start buying on the dips.
JAG is very undervalued at these prices. Here's a recent video about JAG, very informative.
Trade2much, wish I would of seen your catalyst plays from Tuesday.
Looks like LGND has great momentum. Do you see any of them still at deep value/discount?
Agreed. Gold has retracted since January and many junior gold miners have lost 1/2 its market value. However, JAG is down more than 75% since January and the current board needs to be replaced immediately.
Bristol Investment Partners LLC average size account is $18 million.
These big clients will results, Bristol holds almost 10% of JAG and will start the first steps of assembling the board of directors that has the best interest of the shareholders. Who knows, maybe Bristol will force a buyout deal?
http://investment-advisors.findthebest.com/q/23284/3355/What-is-the-average-account-size-at-Bristol-Investment-Partners-Llc
Kei, good job with ARNA. I'm waiting for JAG to run up before taking the profits (Of course, a buyout would be better). I bought more yesterday at $1.30